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BACKGROUND: Chest radiographs are often used to
diagnosecommunity-acquiredpneumonia(CAP),tomon-
itor response to treatment and to ensure complete
resolution of pneumonia. However, radiological exams
may not reflect the actual clinical condition of the patient.
OBJECTIVE: To compare the radiographic resolution of
mild to moderately severe CAP to resolution of clinical
symptoms as assessed by the physician or rated by the
patient.
DESIGN: Prospective cohort study.
PARTICIPANTS: One hundred nineteen patients admit-
ted because of mild to moderately severe CAP with new
pulmonary opacities.
MAIN MEASURES: Radiographic resolution and clinical
cure of CAP were determined at day 10 and 28.
Radiographic resolution was defined as the absence of
infection-related abnormalities; clinical cure was rated
by the physician and defined by improvement of signs
and symptoms. In addition, the CAP score, a patient-
based symptom score, was calculated.
KEY RESULTS: Radiographic resolution, clinical cure
and normalization of the CAP score were observed in
30.8%, 93% and 32% of patients at day 10, and in
68.4%, 88.9% and 41.7% at day 28, respectively. More
severe CAP (PSI score >90) was independently associ-
ated with delayed radiographic resolution at day 28 (OR
4.7, 95% CI 1.3–16.9). All 12 patients with deterioration
of radiographic findings during follow-up had clinical
evidence of treatment failure.
CONCLUSIONS: In mild to moderately severe CAP,
resolution of radiographic abnormalities and resolution
of symptoms scored by the patient lag behind clinical
cure assessed by physicians. Monitoring a favorable
disease process by routine follow-up chest radiographs
seems to have no additional value above following a
patient's clinical course.
KEY WORDS: community-acquired pneumonia; chest radiography;
clinical cure; patients’ perspective; radiology.
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INTRODUCTION
Chest radiography is an important diagnostic tool in patients
suspected of having lower respiratory tract infection to confirm
or exclude a diagnosis of pneumonia.
In addition, chest radiographs are often used to monitor
poor response to treatment and to ensure complete resolution
of pneumonia. In general, radiographs are not recommended
for routine follow-up in patients that are clinically improving,
although these clinical guideline recommendations are only
based on “grade D” recommendations, i.e., expert opinion.
1–4
This lack of evidence may lead to unnecessary use of chest
radiographs in patients hospitalized because of CAP, a practice
that has important health care cost implications given that
CAP is one of the leading causes of hospitalization in the
westernworld.
5–7Moreover,therelationshipbetweenradiological
cure and clinical cure according to the patient’s perspective (self-
reported symptoms) has never been studied.
Therefore, we compared radiographic resolution of CAP to
clinical cure as assessed by the physician or rated by the
patient using a validated symptom score, the CAP score.
8 We
also assessed clinical parameters and etiology associated with
delayed radiographic resolution.
METHODS
Study Population
Details of the study cohort have been reported before.
9 In
short, adults admitted because of mild to moderately severe
CAP [defined as a Pneumonia Severity Index (PSI) score of
≤110] and with radiological evidence of a new opacity were
eligible for inclusion.
10 All patients were initially treated with
intravenous amoxicillin monotherapy.
1 On admission, a phys-
ical exam, routine laboratory test and a chest radiograph were
obtained. Furthermore, we scored pneumonia-related symp-
toms at enrollment using the CAP score, a short patient-based
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203questionnaire. This validated questionnaire contains eight
items for adults admitted to the hospital with CAP based on
respiratory symptoms and on well-being.
8 The survey provides
a CAP respiratory, a CAP well-being and a total CAP score. Low
values indicate more severe symptoms. On admission, patients
were also asked to retrospectively evaluate their symptoms and
general health status 1 month before the onset of pneumonia
(pre-pneumonia score). Patients were followed for a maximum
of 28 days. At each follow-up visit (day 10 and day 28), we
repeatedthechestradiography,physicalexamination,laboratory
analyses and CAP score.
Interpretation of Radiographs
The radiologists on call, who had been provided with informa-
tion on the patient’s clinical condition, evaluated the chest
radiographs. Chest radiographs were reviewed according stan-
dard radiographic criteria for the presence of opacities, pleural
fluid, pulmonary edema, other findings related to infection like
atelectasis and pre-existent abnormalities.
11,
12 Complete
radiographic resolution was defined as the absence of any
chest radiographic abnormality potentially related to infection.
Analytical Approach
To compare time to radiographic resolution of CAP with time to
clinical cure according to the physician and patient, propor-
tions of radiographic resolution, clinical cure and normaliza-
tion of the CAP score were compared at each follow-up visit.
Clinical cure was defined as (continued) resolution or improve-
ment of symptoms and clinical signs related to pneumonia,
without the need for additional or alternative antibiotic therapy
by the opinion of the treating physician.
13 Normalization of the
CAP score was defined as a CAP score equal to or greater than
the initial pre-pneumonia score, and this was regarded as a
proof of clinical cure according to the patient’s perspective.
14
Multivariable regression analysis was performed to assess
parameters associated with delayed radiographic resolution
on day 10 and 28. In all analyses, two-tailed significance levels
of p<0.05 were used. Statistical analysis was performed with
the statistical software package SPSS 15.0. for Windows (SPSS
Inc., Chicago, IL).
RESULTS
Study Population
A total of 119 patients with mild to moderately severe CAP
(mean PSI score 65.5±22.1; mean age 56.6±17.8 years) were
enrolled. About two third of patients (n=79, 66.4%) had at
least one co-morbid illness. In 43 patients (36.1%), a bacterial
etiology was established, with Streptococcus pneumoniae as the
most frequently identified pathogen, in 33 (27.7%) patients.
Data on radiology were obtained in 107 (89.9%) patients at day
10 and in 95 (79.8%) patients at day 28. Eighteen patients
(15.1%) showed complete radiological cure after 10 days, and
these observations were carried forward.
Radiographic Resolution, Clinical Cure
and the CAP Score
Table 1 shows the rates of resolution of radiographic abnor-
malities associated with CAP. Subgroup analysis indicated
that radiographic resolution was slightly slower in patients
with S. pneumoniae infection as compared to other etiologies,
24.1% vs. 31.9% at day 10 and 56.0% vs. 69.4% at day 28,
respectively.
After 10 days of follow-up, clinical cure (physician based)
was observed in 106/114 patients (93.0%), normalization of
the CAP score in 33/103 patients (32.0%) and radiographic
resolution in 33/105 patients (30.8%). At day 28, continued
clinical cure was observed in 96/108 patients (88.9%), where-
as 43/103 (41.7%) had normalization of the CAP score and
65/95 (68.4%) had complete radiographic resolution. Patients
with radiographic resolution at day 10 and day 28 had
significantly higher CAP well-being scores at day 10 (62.5 vs.
Table 1. Patterns of Resolution of Radiological Abnormalities Associated with CAP
Day No. Cumulative dropout
a
no. (%)
Chest radiograph findings
No. (%)
Normal Opacities Pleural fluid Pulmonary edema Atelectasis/ other findings
related to infection
0 119 0 (0%) 0 (0%) 119 (100%) 11 (9.2%) 5 (4.2%) 6 (5.0%)
10 107 12 (10.1%) 33 (30.8%) 65 (60.7%) 17 (15.9%) 0 (0%) 15 (14.0%)
28 95 24 (20.2%) 65 (68.4%) 23 (24.2%) 4 (4.2%) 0 (0%) 9 (9.5%)
aCumulative dropout reflects the number of patients in whom no follow-up radiography was performed
Figure 1. Clinical symptoms rated by patients (CAP score)
according to radiographic resolution of CAP.
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to patients without radiographic resolution of CAP (Fig. 1).
Delayed Radiographic Resolution and Clinical
Cure
At day 10, 62 patients (57.9%) had an incomplete radiological
response and at day 28 days 30 patients (31.6%); 12/107
(11.2%) patients had deterioration of radiological findings
during follow-up. All patients with radiological deterioration
had one or more clinical or laboratory signs suggesting clinical
failure: fever (n=11), abnormal auscultatory findings (n=5),
high respiration rate (n=1), increased inflammatory markers
(n=5) or delayed normalization of the CAP score (n=10). None
of the patients developed deterioration of chest radiography
during the second part of follow-up (day 10–day 28).
Multivariable analysis demonstrated that dyspnea on ad-
mission was independently associated with delayed radio-
graphic resolution at day 10 (OR 7.4, 95% CI 2.1–26.0; p=
0.002), whereas COPD was associated with a faster radiolog-
ical recovery (OR 0.3, 95% CI 0.1–0.8; p=0.01). At day 28, only
a PSI score >90 was identified as an independent predictor of
delayed radiographic resolution (OR 4.7, 95% CI 1.3–16.9;
p=0.02).
DISCUSSION
We found that about a third of patients (30%) with mild to
moderately severe CAP had radiographic resolution after
10 days and 70% after 1 month. This is comparable to
previous studies that reported radiological cure rates of
35.1% to 87% 3 to 4 weeks after diagnosis of CAP.
15–18 We
used a more strict definition of radiological cure that might
underestimate radiological cure rate, because patients with
some improvement on chest radiography were classified as
having no radiological cure. This stricter definition makes good
clinical sense since confirmation of complete radiological
clearance is important to exclude a non-infectious underlying
cause of pneumonia or radiographic abnormalities, such as
obstructing tumors.
We also showed that radiological cure and resolution of
symptoms as rated by patients lags behind clinical cure as
assessed by physicians. Apparently, when patients are consid-
ered cured by their physician, they do not feel they are back to
baseline.
Patients with pneumococcal pneumonia had a slower
resolution of infectious-related findings on the chest radio-
graph as compared to patients with a viral or unknown etiology
of pneumonia. This is line with several previous studies
demonstrating a slower resolution in pneumococcal and
legionella pneumonia as compared to other etiologies.
5, 19
The reason for delayed radiological cure in a S. pneumoniae
infections may be explained by the development of complica-
tions that are related to pneumococcal pneumonia, like pleural
effusion or empyema.
20 The severity of CAP was also an
independent predictor of delayed radiographic resolution,
similar to our previous studies in severe CAP where rates of
radiographic resolution were lower than in current study of
mild to moderately severe CAP (1 week: 25% vs 50%, 1 month:
30% vs 70%).
5
All 12 patients who experienced deterioration of the chest
radiograph during follow-up had clinical signs of deterioration.
Since only 30% of patients had radiological cure at 10 days,
incomplete resolution of pulmonary infiltrates in the absence of
clinical deterioration should not be a reason for treatment
changes.
In conclusion, complete radiological clearance rate in
patients with mild to moderately severe pneumonia is 30%
after 10 days and 70% after 1 month. Severity of pneumonia
on admission was associated with delayed radiological clear-
ance. Radiographic resolution and resolution of symptoms as
scored by the patient lag behind clinical cure as assessed by
physicians. All patients with deterioration of radiographic
findings during follow-up had clinical evidence of treatment
failure. Therefore, monitoring a favorable disease process by
means of routine short-term follow-up chest radiography in
patients with mild to moderately severe CAP leads to unnec-
essary resource use and has no additional value above clinical
decisions based on patient’s clinical symptoms. Based on the
present study, follow-up chest radiographs to exclude under-
lying diseases should not be performed within 4 weeks after
initial diagnosis. Further studies to more clearly define an
optimal time frame for follow-up chest radiographs, or if such
follow-up is ever indicated, are needed.
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